Cyclin D1, a Novel Molecular Marker of Minimal Residual Disease, in Metastatic Neuroblastoma

Accurate monitoring of minimal residual disease (MRD) is critical for the management of metastatic neuroblastoma (NB). We evaluated cyclin D1 (CCND1), a cell-cycle control gene, as a novel MRD marker of NB. Using quantitative reverse transcriptase-polymerase chain reaction, we studied CCND1 expressi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cheung, Irene Y., Feng, Yi, Vickers, Andrew, Gerald, William, Cheung, Nai-Kong V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Investigative Pathology 2007
Aiheet:
Regular Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1867438/
https://ncbi.nlm.nih.gov/pubmed/17384216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/jmoldx.2007.060130
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia